Adhesion molecule expression in CD5-negative/CD10-negative chronic B-cell leukemias: Comparison with non-Hodgkin's lymphomas and CD5-positive B-cell chronic lymphocytic leukemia

Human Pathology

Volumn 32, Issue 1, 2001, Pages 66-73

  Finn, William G ^a   Singleton, Timothy P ^a   Schnitzer, Bertram ^a   Ross, Charles W ^a   Stoolman, Lloyd M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Adhesion molecules; Chronic lymphocytic leukemia; Non Hodgkin's lymphoma

Indexed keywords

CD5 ANTIGEN; CELL ADHESION MOLECULE; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN;

ARTICLE; B CELL LEUKEMIA; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; LYMPHOCYTE SUBPOPULATION; NONHODGKIN LYMPHOMA; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TISSUE DISTRIBUTION;

EID: 0035126318     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1053/hupa.2001.20891     Document Type: Article

References (51)

1. Proposals for the classification of chronic (mature) B and T lymphoid leukemias
2. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: Revised guidelines for diagnosis and treatment
3. Clinical utility of flow cytometry in the chronic lymphoid leukemias
4. The pathology of the chronic lymphoid leukemias
5. Immunophenotyping of subtypes of B-chronic (mature) lymphoid leukemia. A study of 242 cases
6. Prognostic importance of flow cytometric immunophenotyping of 540 consecutive patients with B-cell chronic lymphocytic leukemia
7. Mantle cell lymphoma - An entity comes of age
8. Morphology and immunology of circulating cells in leukaemic phase of follicular lymphoma
9. CD5(-) small B-cell leukemias are rarely classifiable as chronic lymphocytic leukemia
10. The immunophenotype of splenic lymphoma with villous lymphocytes and its relevance to the differential diagnosis with other B-cell disorders
11. CD5 positive and negative B-CLL. Evidence supporting phenotypic heterogeneity in B-chronic lymphocytic leukemia (B-CLL)
12. A scoring system for the classification of CD5-B CLL versus CD5+ B CLL and B PLL
13. CD5- B-cell lymphoproliferative disorders presenting in blood and bone marrow. A clinicopathologic study of 40 patients
14. CD5 negative lymphocytosis mimicking typical B-chronic lymphocytic leukemia. Description of 26 cases
15. CD5 negative B-cell chronic lymphocytic leukemia: Clinical and biological features of 42 cases
16. Lymphocyte homing and homeostasis
17. Adhesion molecules in B-chronic lymphoproliferative disorders
18. Expression and function of adhesion receptors on normal B cells and B cell non-Hodgkin's lymphomas
19. Expression of adhesion molecules in chornic B-cell lymphoproliferative disorders
20. Adhesion molecule expression on B-cell chronic lymphocytic leukemia cells: Malignant cell phenotypes define distinct disease subsets
21. Cell adhesion receptors in lymphoma dissemination
22. "Small" B-cell non-Hodgkin's lymphomas with splenomegaly at presentation are either mantle cell lymphoma or marginal zone cell lymphoma. A study based on histology, cytology, immunohistochemistry, and cytogenetic analysis
23. A role for the VLA-4 integrin in the activation of human memory B cells
24. Differential expression of very late activation antigen-3 (VLA-3)/VLA-4 in B-cell non-Hodgkin lymphoma and B-cell chronic lymphocytic leukemia
25. Preferential dissemination of B-cell gastric mucosa-associated lymphoid tissue (MALT) lymphoma to the splenic marginal zone
26. Distribution of alpha 4 beta 7 and alpha E beta 7 integrins on thymocytes, intestinal epithelial lymphocytes and peripheral lymphocytes
27. Expression of the mucosal vascular addressin, MAdCAM-1, on sinus-lining cells in the spleen
28. Human mucosal addressin cell adhesion molecule-1 is preferentially expressed in intestinal tract and associated lymphoid tissue
29. Preferential expression of the mucosal homing receptor integrin alpha 4 beta 7 in gastrointestinal non-Hodgkin's lymphomas
30. Adhesion receptors on peripheral blood leukemic B cells. A comparative study on B cell chronic lymphocytic leukemia and related lymphoma/leukemias
31. Regulation of leukocyte adhesion molecule-1 (TQ1, Leu-8) expression and shedding by normal and malignant cells
32. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group
33. Karyotype correlates with peripheral blood morphology and immunophenotype in chronic lymphocytic leukemia
34. Coordinate expression of beta 1 and beta 2 integrin "activation" epitopes during T cell responses in secondary lymphoid tissue
35. HML-1 antigen on mucosa-associated T cells, activated cells, and hairy leukemic cells is a new integrin containing the beta 7 subunit
36. Nonparametric estimation from incomplete observations
37. Splenic lymphoma with circulating villous lymphocytes/splenic marginal-zone lymphoma
38. The concept of typical and atypical chronic lymphocytic leukemia
39. 2-Chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia and hairy cell leukemia variant: 7-Year experience in Poland
40. Hairy cell leukemia-variant treated with 2-chlorodeoxyadenosine - A report of three cases
41. 2-Chlorodeoxyadenosine in the treatment of hairy cell leukemia: Differences in response in patients with and without abdominal lymphadenopathy
42. Adhesion molecules in the dissemination of non-Hodgkin's lymphomas
43. CD11c (LEU-M5) expression characterizes a B-cell chronic lymphoproliferative disorder with features of both chronic lymphocytic leukemia and hairy cell leukemia
44. Old and new therapies in chronic lymphocytic leukemia: Now is the time for a reassessment of therapeutic goals
45. Distinct recirculating and non-recirculating B-lymphocyte pools in the peripheral blood are defined by coordinated expression of CD21 and L-selectin
46. Topographic distribution of homing receptors on B and T cells in human gut-associated lymphoid tissue: Relation of L-selectin and integrin alpha 4 beta 7 to naive and memory phenotypes
47. Primary nodal marginal zone lymphomas of splenic and MALT type
48. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia
49. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia
50. The immunophenotype of hairy cell leukemia (HCL). Proposal for a scoring system to distinguish HCL from B-cell disorders with hairy or villous lymphocytes
51. Relationship between hairy cell leukemia variant and splenic lymphoma with villous lymphocytes: Presentation of a new concept